Summary
The in situ response of clonogenic cells in murine intestinal crypts to graded doses of 12 clinically used cytotoxic drugs has been measured by the crypt microcolony assay. For the alkylating agents mechlorethamine hydrochloride and BCNU, survival curves down to three logs of crypt depletion could be obtained. However, with isopropyl methane sulphonate only one log of depletion was measurable, and for a fourth alkylating agent, cyclophosphamide, no crypt killing occurred before other toxicities resulted in death of the animal in less than 3–4 days. This is the major constraint on the use of the microcolony assay with cytotoxic drugs. Of four antibiotics, survival curves were obtainable for adriamycin, bleomycin and mitomycin C, but not for actinomycin D. 5-Fluorouracil gave only a limited degree of crypt kill. Of three S-phase-specific drugs, hydroxyurea and vincristine resulted in little or no crypt depletion, but there was dose-dependent crypt depletion after methotrexate. The complexities of applying cellular-kinetic classifications of cytotoxic drugs to in situ endpoints are discussed.
Similar content being viewed by others
References
Gilbert CW (1974) A double minus log transformation of mortality probabilities. Int J Radiat Biol 25:633
Hanson WR, Henninger DL, Fry RJM (1979) Time dependence of intestinal proliferative cell risk vs stem cell risk to radiation or colcemid cytotoxicity following hydroxyurea. Int J Radiat Oncol Biol Phys 5:1685
Hendry JH, Potten CS (1974) Cryptogenic cells and proliferative cells in intestinal epithelium. Int J Radiat Biol 25:583
Hendry JH, Moore JV, Potten CS (1984) The proliferative status of microcolony-forming cells in mouse small intestine. Cell Tissue Kinet 17:41
Lohrmann H-P, Schreml W (1982) Cytotoxic drugs and the granulopoietic system. Springer, Berlin Heidelberg New York
Maase H von der, Overgaard J (1983) Microcolony survival assay for jejunal crypt cells exposed to radiation alone and combined with cancer chemotherapeutic agents — methodological problems. Int J Radiat Biol 43:45
Moore JV (1984a) Death of intestinal crypts and of their constituent cells after treatment by chemotherapeutic drugs. Br J Cancer 49:25
Moore JV (1984b) Examination of the correlation of ‘first week’ mortality with the gastrointestinal syndrome, following chemotherapy. Cancer Treat Rep 68:1005
Moore JV, Hendry JH (1978) Response of murine jejunal crypts to single doses of cyclophosphamide and radiation. Int J Radiat Oncol Biol Phys 4:415
Moore JV, Pearson D, Deakin DP (1982) Gross and cellular response of intestinal crypts to single and fractionated doses of vincristine plus radiation: the influence of time between modalities. Int J Radiat Biol 42:305
Phillips TL (1980) Clinical and experimental alterations in the radiation therapeutic ratio caused by cytotoxic chemotherapy: In: Meyn RE, Withers HR (eds) Radiation biology in cancer research. Raven Press, New York, p 567
Potten CS, Hendry JH (1983) Stem cells in murine small intestine: In: Potten CS (ed) Stem cells. Churchill-Livingstone, Edinburgh, p 155
Sirotnak FM, Moccio DM (1980) Pharmacokinetic basis for differences in methotrexate sensitivity of normal proliferative tissues in the mouse. Cancer Res 40:1230
Withers HR, Elkind MM (1970) Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol 17:261
Author information
Authors and Affiliations
Additional information
The work reported in this paper was supported by the Cancer Research Campaign
Rights and permissions
About this article
Cite this article
Moore, J.V. Clonogenic response of cells of murine intestinal crypts to 12 cytotoxic drugs. Cancer Chemother. Pharmacol. 15, 11–15 (1985). https://doi.org/10.1007/BF00257286
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00257286